PT-141

PT-141

PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin-receptor agonist derived from Melanotan II, studied as a research material. It is not a BPC analog and it is not a phenethylamine. This listing is for laboratory research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not approved for human or veterinary use.

Research Context

PT-141 appears in the scientific literature as a melanocortin agonist examined at MC3R and MC4R in central-pathway models, originating from the Melanotan II analog series. This page does not describe administration, dosing, or personal use.

Research Overview

Published work has examined PT-141 in controlled experimental systems of melanocortin-receptor signaling. Findings from those models are not established as safe or effective for people or animals, and nothing here is medical advice.

Key Research Focus Areas

• Cyclic melanocortin-receptor agonist identity (bremelanotide)
• MC3R / MC4R binding and signaling assays
• Central melanocortin pathway models
• Structural relationship to Melanotan II, distinct from BPC-157

Important Disclaimer

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not medical advice. Handle only in a qualified research setting and in compliance with applicable law.